CounterAct Day is a Oral Tablet, Film Coated in the Human Otc Drug category. It is labeled and distributed by Melaleuca, Inc.. The primary component is Acetaminophen; Dextromethorphan Hydrobromide; Guaifenesin; Phenylephrine Hydrochloride.
| Product ID | 54473-185_65e42ef2-d090-6174-e053-2991aa0a9830 |
| NDC | 54473-185 |
| Product Type | Human Otc Drug |
| Proprietary Name | CounterAct Day |
| Generic Name | Acetaminophen, Dextromethorphan Hbr, Guaifenesin, Phenylephrine |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2011-10-01 |
| Marketing Category | OTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL |
| Application Number | part341 |
| Labeler Name | Melaleuca, Inc. |
| Substance Name | ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE |
| Active Ingredient Strength | 325 mg/1; mg/1; mg/1; mg/1 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2018-01-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | OTC monograph final |
| Application Number | part341 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2018-01-01 |
| Marketing End Date | 2019-12-31 |
| Ingredient | Strength |
|---|---|
| ACETAMINOPHEN | 325 mg/1 |
| SPL SET ID: | 07ee5376-e907-4183-b49a-67f5e894836c |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |